520 related articles for article (PubMed ID: 26609865)
21. RNAi therapeutics: the teenage years.
Perkel JM
Biotechniques; 2012 Jun; 52(6):355-7. PubMed ID: 22668413
[No Abstract] [Full Text] [Related]
22. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.
Li SD; Huang L
Curr Opin Investig Drugs; 2008 Dec; 9(12):1317-23. PubMed ID: 19037838
[TBL] [Abstract][Full Text] [Related]
23. Current Progress in Non-viral RNAi-Based Delivery Strategies to Lymphocytes.
Mizrahy S; Hazan-Halevy I; Dammes N; Landesman-Milo D; Peer D
Mol Ther; 2017 Jul; 25(7):1491-1500. PubMed ID: 28392163
[TBL] [Abstract][Full Text] [Related]
24. Chitosan-based nanoparticles for mucosal delivery of RNAi therapeutics.
Martirosyan A; Olesen MJ; Howard KA
Adv Genet; 2014; 88():325-52. PubMed ID: 25409611
[TBL] [Abstract][Full Text] [Related]
25. Targeted delivery of short interfering RNAs--strategies for in vivo delivery.
Wullner U; Neef I; Tur MK; Barth S
Recent Pat Anticancer Drug Discov; 2009 Jan; 4(1):1-8. PubMed ID: 19149683
[TBL] [Abstract][Full Text] [Related]
26. Targeted delivery systems of small interfering RNA by systemic administration.
Kawakami S; Hashida M
Drug Metab Pharmacokinet; 2007 Jun; 22(3):142-51. PubMed ID: 17603214
[TBL] [Abstract][Full Text] [Related]
27. Generation of siRNA Nanosheets for Efficient RNA Interference.
Kim H; Lee JS; Lee JB
Sci Rep; 2016 Apr; 6():25146. PubMed ID: 27120975
[TBL] [Abstract][Full Text] [Related]
28. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
Aigner A
J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
[TBL] [Abstract][Full Text] [Related]
29. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.
DeVincenzo JP
Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462
[TBL] [Abstract][Full Text] [Related]
30. Enhanced Delivery of siRNA to Retinal Ganglion Cells by Intravitreal Lipid Nanoparticles of Positive Charge.
Huang X; Chau Y
Mol Pharm; 2021 Jan; 18(1):377-385. PubMed ID: 33295773
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic siRNA: principles, challenges, and strategies.
Gavrilov K; Saltzman WM
Yale J Biol Med; 2012 Jun; 85(2):187-200. PubMed ID: 22737048
[TBL] [Abstract][Full Text] [Related]
32. Multifunctional Oligoaminoamides for the Receptor-Specific Delivery of Therapeutic RNA.
Weber J; Lächelt U; Wagner E
Methods Mol Biol; 2015; 1324():369-86. PubMed ID: 26202283
[TBL] [Abstract][Full Text] [Related]
33. Interfering with disease: a progress report on siRNA-based therapeutics.
de Fougerolles A; Vornlocher HP; Maraganore J; Lieberman J
Nat Rev Drug Discov; 2007 Jun; 6(6):443-53. PubMed ID: 17541417
[TBL] [Abstract][Full Text] [Related]
34. Development of RNA interference-based therapeutics and application of multi-target small interfering RNAs.
Li T; Wu M; Zhu YY; Chen J; Chen L
Nucleic Acid Ther; 2014 Aug; 24(4):302-12. PubMed ID: 24796432
[TBL] [Abstract][Full Text] [Related]
35. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
[TBL] [Abstract][Full Text] [Related]
36. Systemic Modulation of Lymphocyte Subsets Using siRNAs Delivered via Targeted Lipid Nanoparticles.
Hazan-Halevy I; Rosenblum D; Ramishetti S; Peer D
Methods Mol Biol; 2019; 1974():151-159. PubMed ID: 31099001
[TBL] [Abstract][Full Text] [Related]
37. Small Interfering RNAs and their Delivery Systems: A Novel Powerful Tool for the Potential Treatment of HIV Infections.
Bolhassani A; Milani A
Curr Mol Pharmacol; 2020; 13(3):173-181. PubMed ID: 31760929
[TBL] [Abstract][Full Text] [Related]
38. Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs.
Dykxhoorn DM; Lieberman J
Annu Rev Biomed Eng; 2006; 8():377-402. PubMed ID: 16834561
[TBL] [Abstract][Full Text] [Related]
39. PAMAM Dendrimers as a Delivery System for Small Interfering RNA.
Kheiriabad S; Ghaffari M; Dolatabadi JEN; Hamblin MR
Methods Mol Biol; 2020; 2115():91-106. PubMed ID: 32006396
[TBL] [Abstract][Full Text] [Related]
40. Molecular design and delivery of siRNA.
Inoue A; Sawata SY; Taira K
J Drug Target; 2006; 14(7):448-55. PubMed ID: 17062391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
